Zevalin (ibritumomab tiuxetan) injection
Ended Awarded Last action
- Contract number
- HT001415F0031
- Awardee
-
Spectrum Pharmaceuticals, Inc. UEI SC4WFM7J1EJ3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $77,673
Award facts
- Contract value 100% obligated
- $77,672.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Bureau of Medicine and Surgery Department of the Navy, Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q522 Medical- Radiology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Henderson, NV 89052, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $7,995 | |
| Original award | $69,678 |
Quick answers
Who was awarded contract HT001415F0031?
HT001415F0031 was awarded to Spectrum Pharmaceuticals, Inc. by Defense Health Agency (Department of Defense) on December 2, 2014.
How much is contract HT001415F0031 worth?
The government has obligated $77,673 on HT001415F0031.
Which agency awarded contract HT001415F0031?
Defense Health Agency (Department of Defense) awarded HT001415F0031, with funding from Bureau of Medicine and Surgery (Department of the Navy).
Is contract HT001415F0031 an order under another contract?
Yes. HT001415F0031 is a delivery order under V797P5025B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract HT001415F0031 competed?
The extent of competition for HT001415F0031 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award